RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score-Reference-Cited by-同舟云学术

RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

Published:2019-05-20 Issue:8 Volume:26 Page:2595-2604
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Arjona-Sanchez A.,Rodriguez-Ortiz L.,Baratti D.,Schneider M. A.,Gutiérrez-Calvo A.,García-Fadrique A.,Tuynman J. B.,Cascales-Campos P. A.,Martín V. Concepción,Morales R.,Salti G. I.,Arteaga X.,Pacheco D.,Alonso-Gomez J.,Yalkin O.,Villarejo-Campos P.,Sanchez-Hidalgo J. M.,Casado-Adam A.,Cosano-Alvarez A.,Rufian-Peña S.,Briceño J.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-07378-9.pdf

Reference23 articles.

1. Mirnezami R, Mehta AM, Chandrakumaran K, et al. Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer. 2014;111:1500–8.

2. Arjona-Sánchez A, et al. Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: an overview. World J Gastrointest Oncol. 2014;6:407.

3. Franko J, Ibrahim Z, Gusani NJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer. 2010;116:3756–62.

4. Cavaliere F, De Simone M, Virz S, et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2011; 37: 148–54.

5. Kwakman R, Schrama AM, van Olmen JP, et al. Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis. Ann Surg. 2016;263(6):1102–11.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-09

2. Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?;Advances in Surgery;2024-09

3. Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2024-08-11

4. Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases;ESMO Open;2024-04

5. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer;Cancers;2023-11-29